12 April 2011 – trading update & management appointments

Revenue for the year ended 31 March 2011 is expected to be £7.9m, up 27% on the previous year. Most product groups have seen solid growth and the food intolerance business has been a star performer.

There have also been 3 senior management appointments, which will help drive the business forward. Over the longer term prospects look very good. Although we believe the relatively recent placing at 12p per share will cause a drag on the price for some time, the shares are very good value based on fundamentals. On that basis they are a LONG TERM BUY.